Bayot, Baby Boy L.
HRN: 24-96-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2024
AMPICILLIN 250MG (VIAL)
05/16/2024
05/23/2024
IV
190mg
Q12
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes